The Pathologist, in collaboration with Leica Biosystems, would like to invite you to a fascinating webinar that will investigate the impact of laser microdissection in the clinic on KRAS/NRAS/EGFR mutation analysis and personalized cancer treatment.
Colorectal cancer is the third most common cancer and the fourth leading cause of cancer-related death.
Dr Klaus Hermann Wiedorn will explain how laser microdissection allows extraction of defined cell populations, enabling pathologists to select target cell samples for downstream testing. The added sampling specificity allows better stratification of patients, more effective targeted therapy, and, ultimately, better outcomes.
If you would like to attend, or if you would like to download the event at a later date, simply click on the link to register:
Laser Microdissection in Clinical Practice: Impact on KRAS/NRAS/EGFR Mutation Analysis and Personalized Cancer Treatment
Tuesday 23rd May 2017, 17:00 CET